These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29724722)

  • 21. Erythrocyte aging as a mechanism of anemia and a biomarker of device thrombosis in continuous-flow left ventricular assist devices.
    Taimeh Z; Koene RJ; Furne J; Singal A; Eckman PM; Levitt MD; Pritzker MR
    J Heart Lung Transplant; 2017 Jun; 36(6):625-632. PubMed ID: 28396088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Continuous-Flow Left Ventricular Assist Device Therapy on Peripheral Vascular Function.
    Kaya E; Kocabas U; Simsek E; Nalbantgil S; Kahraman U; Engin C; Yagdi T; Ozbaran M; Akilli A
    ASAIO J; 2022 Feb; 68(2):214-219. PubMed ID: 35089263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arterial pulsatility improvement in a feedback-controlled continuous flow left ventricular assist device: an ex-vivo experimental study.
    Bozkurt S; van Tuijl S; Schampaert S; van de Vosse FN; Rutten MC
    Med Eng Phys; 2014 Oct; 36(10):1288-95. PubMed ID: 25066581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of aortic valve commissural fusion after support with continuous-flow left ventricular assist device.
    Martina JR; Schipper ME; de Jonge N; Ramjankhan F; de Weger RA; Lahpor JR; Vink A
    Interact Cardiovasc Thorac Surg; 2013 Oct; 17(4):616-24. PubMed ID: 23798641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PTEN deficiency promotes pathological vascular remodeling of human coronary arteries.
    Moulton KS; Li M; Strand K; Burgett S; McClatchey P; Tucker R; Furgeson SB; Lu S; Kirkpatrick B; Cleveland JC; Nemenoff RA; Ambardekar AV; Weiser-Evans MC
    JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices.
    Frazier OH; Baldwin AC; Demirozu ZT; Segura AM; Hernandez R; Taegtmeyer H; Mallidi H; Cohn WE
    J Heart Lung Transplant; 2015 Jun; 34(6):766-72. PubMed ID: 25447571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular reverse remodeling with a continuous flow left ventricular assist device measured by left ventricular end-diastolic dimensions and severity of mitral regurgitation.
    Morgan JA; Brewer RJ; Nemeh HW; Murthy R; Williams CT; Lanfear DE; Tita C; Paone G
    ASAIO J; 2012; 58(6):574-7. PubMed ID: 23103696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New therapy, new challenges: The effects of long-term continuous flow left ventricular assist device on inflammation.
    Grosman-Rimon L; Billia F; Fuks A; Jacobs I; A McDonald M; Cherney DZ; Rao V
    Int J Cardiol; 2016 Jul; 215():424-30. PubMed ID: 27131263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
    Klotz S; Foronjy RF; Dickstein ML; Gu A; Garrelds IM; Danser AH; Oz MC; D'Armiento J; Burkhoff D
    Circulation; 2005 Jul; 112(3):364-74. PubMed ID: 15998679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices.
    Gopinathannair R; Birks EJ; Trivedi JR; McCants KC; Sutton BS; Deam AG; Slaughter MS; Hottigoudar RU
    J Card Fail; 2015 Mar; 21(3):226-32. PubMed ID: 25528199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased cyclic guanosine monophosphate levels and continuous-flow left-ventricular assist devices: Implications for gastrointestinal bleeding.
    Grosman-Rimon L; Tumiati LC; Fuks A; Jacobs I; Lalonde SD; Cherney DZ; Rao V
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):219-27. PubMed ID: 26515873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Nasal Mucosal Vascular Alterations, Gastrointestinal Arteriovenous Malformations, and Bleeding in Patients With Continuous-Flow Left Ventricular Assist Devices.
    Patel SR; Madan S; Saeed O; Algodi M; Luke A; Gibber M; Goldstein DJ; Jorde UP
    JACC Heart Fail; 2016 Dec; 4(12):962-970. PubMed ID: 27744088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.
    Klotz S; Barbone A; Reiken S; Holmes JW; Naka Y; Oz MC; Marks AR; Burkhoff D
    J Am Coll Cardiol; 2005 Mar; 45(5):668-76. PubMed ID: 15734609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
    Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arterial wall histology in chronic pulsatile-flow and continuous-flow device circulatory support.
    Potapov EV; Dranishnikov N; Morawietz L; Stepanenko A; Rezai S; Blechschmidt C; Lehmkuhl HB; Weng Y; Pasic M; Hübler M; Hetzer R; Krabatsch T
    J Heart Lung Transplant; 2012 Nov; 31(11):1171-6. PubMed ID: 22995552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and histopathological effects of heart failure drug therapy in advanced heart failure patients on chronic mechanical circulatory support.
    Catino AB; Ferrin P; Wever-Pinzon J; Horne BD; Wever-Pinzon O; Kfoury AG; McCreath L; Diakos NA; McKellar S; Koliopoulou A; Bonios MJ; Al-Sarie M; Taleb I; Dranow E; Fang JC; Drakos SG
    Eur J Heart Fail; 2018 Jan; 20(1):164-174. PubMed ID: 29094485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidative stress induced modulation of platelet integrin α2bβ3 expression and shedding may predict the risk of major bleeding in heart failure patients supported by continuous flow left ventricular assist devices.
    Mondal NK; Chen Z; Trivedi JR; Sorensen EN; Pham SM; Slaughter MS; Griffith BP; Wu ZJ
    Thromb Res; 2017 Oct; 158():140-148. PubMed ID: 28915447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure.
    Lee SH; Doliba N; Osbakken M; Oz M; Mancini D
    J Thorac Cardiovasc Surg; 1998 Aug; 116(2):344-9. PubMed ID: 9699589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.